Kate Haviland
CIK 1663022 · Chief Executive Officer · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
54
Lifetime Open-Market Net
-$13.58M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 4 of 6
54 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-09-24 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$217.5K | EDGAR |
| 2020-06-15 | FULC | Grant (A) | — | $0 | EDGAR |
| 2020-03-11 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −671 | -$34.9K | EDGAR |
| 2020-03-03 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | +18,894 | $75.6K | EDGAR |
| 2020-01-14 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$534.7K | EDGAR |
| 2019-08-21 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$6.5K | EDGAR |
| 2019-07-18 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | +9,991 | $38.2K | EDGAR |
| 2019-07-18 | FULC | Grant (A) | — | $0 | EDGAR |
| 2019-06-19 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$846.3K | EDGAR |
| 2019-03-05 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | — | -$1.34M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.